BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38477138)

  • 1. Effectiveness of lapatinib for enhancing 5-aminolevulinic acid-mediated protoporphyrin IX fluorescence and photodynamic therapy in human cancer cell lines with varied ABCG2 activities.
    Howley R; Olsen J; Chen B
    Photochem Photobiol; 2024 Mar; ():. PubMed ID: 38477138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of ABCG2 transporter by lapatinib enhances 5-aminolevulinic acid-mediated protoporphyrin IX fluorescence and photodynamic therapy response in human glioma cell lines.
    Mansi M; Howley R; Chandratre S; Chen B
    Biochem Pharmacol; 2022 Jun; 200():115031. PubMed ID: 35390338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of aminolevulinic acid-mediated protoporphyrin IX fluorescence and enhancement by ABCG2 inhibitors in renal cell carcinoma cells.
    Howley R; Mansi M; Shinde J; Restrepo J; Chen B
    J Photochem Photobiol B; 2020 Oct; 211():112017. PubMed ID: 32919173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small molecule kinase inhibitors enhance aminolevulinic acid-mediated protoporphyrin IX fluorescence and PDT response in triple negative breast cancer cell lines.
    Palasuberniam P; Kraus D; Mansi M; Howley R; Braun A; Myers K; Chen B
    J Biomed Opt; 2021 Sep; 26(9):. PubMed ID: 34545713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting ABCG2 transporter to enhance 5-aminolevulinic acid for tumor visualization and photodynamic therapy.
    Chandratre S; Olsen J; Howley R; Chen B
    Biochem Pharmacol; 2023 Nov; 217():115851. PubMed ID: 37858868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ABCG2 transporter inhibitor restores the sensitivity of triple negative breast cancer cells to aminolevulinic acid-mediated photodynamic therapy.
    Palasuberniam P; Yang X; Kraus D; Jones P; Myers KA; Chen B
    Sci Rep; 2015 Aug; 5():13298. PubMed ID: 26282350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accumulation of protoporphyrin IX in medulloblastoma cell lines and sensitivity to subsequent photodynamic treatment.
    Briel-Pump A; Beez T; Ebbert L; Remke M; Weinhold S; Sabel MC; Sorg RV
    J Photochem Photobiol B; 2018 Dec; 189():298-305. PubMed ID: 30445362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial localization of ABC transporter ABCG2 and its function in 5-aminolevulinic acid-mediated protoporphyrin IX accumulation.
    Kobuchi H; Moriya K; Ogino T; Fujita H; Inoue K; Shuin T; Yasuda T; Utsumi K; Utsumi T
    PLoS One; 2012; 7(11):e50082. PubMed ID: 23189181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pivotal roles of peptide transporter PEPT1 and ATP-binding cassette (ABC) transporter ABCG2 in 5-aminolevulinic acid (ALA)-based photocytotoxicity of gastric cancer cells in vitro.
    Hagiya Y; Endo Y; Yonemura Y; Takahashi K; Ishizuka M; Abe F; Tanaka T; Okura I; Nakajima M; Ishikawa T; Ogura S
    Photodiagnosis Photodyn Ther; 2012 Sep; 9(3):204-14. PubMed ID: 22959800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABCG2 influence on the efficiency of photodynamic therapy in glioblastoma cells.
    Müller P; Abdel Gaber SA; Zimmermann W; Wittig R; Stepp H
    J Photochem Photobiol B; 2020 Sep; 210():111963. PubMed ID: 32795847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of the efficacy of 5-aminolevulinic acid-mediated photodynamic treatment in human oral squamous cell carcinoma HSC-4.
    Yamamoto M; Fujita H; Katase N; Inoue K; Nagatsuka H; Utsumi K; Sasaki J; Ohuchi H
    Acta Med Okayama; 2013; 67(3):153-64. PubMed ID: 23804138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel potential photodynamic therapy strategy using 5-Aminolevulinic acid for ovarian clear-cell carcinoma.
    Teshigawara T; Mizuno M; Ishii T; Kitajima Y; Utsumi F; Sakata J; Kajiyama H; Shibata K; Ishizuka M; Kikkawa F
    Photodiagnosis Photodyn Ther; 2018 Mar; 21():121-127. PubMed ID: 29196245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methods to Measure the Inhibition of ABCG2 Transporter and Ferrochelatase Activity to Enhance Aminolevulinic Acid-Protoporphyrin IX Fluorescence-Guided Tumor Detection and Resection.
    Mansi M; Howley R; Chen B
    Methods Mol Biol; 2022; 2394():823-835. PubMed ID: 35094360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of therapeutic efficacy of 5-aminolevulinic acid-based photodynamic therapy in human prostate cancer.
    Yamamoto S; Fukuhara H; Seki H; Kawada C; Nakayama T; Karashima T; Ogura SI; Inoue K
    Photodiagnosis Photodyn Ther; 2021 Sep; 35():102452. PubMed ID: 34303032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Aminolevulinic Acid as a Theranostic Agent for Tumor Fluorescence Imaging and Photodynamic Therapy.
    Howley R; Chandratre S; Chen B
    Bioengineering (Basel); 2023 Apr; 10(4):. PubMed ID: 37106683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical role of ABCG2 in ALA-photodynamic diagnosis and therapy of human brain tumor.
    Ishikawa T; Kajimoto Y; Inoue Y; Ikegami Y; Kuroiwa T
    Adv Cancer Res; 2015; 125():197-216. PubMed ID: 25640271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mangostin enhances efficacy of aminolevulinic acid-photodynamic therapy against cancer through inhibition of ABCG2 activity.
    Lai HW; Tani Y; Sukatta U; Rugthaworn P; Thepyos A; Yamamoto S; Fukuhara H; Inoue K; Yuasa H; Nakamura H; Ogura SI
    Photodiagnosis Photodyn Ther; 2023 Dec; 44():103798. PubMed ID: 37696317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of Cancer-Specific Protoporphyrin IX Fluorescence by Targeting Oncogenic Ras/MEK Pathway.
    Yoshioka E; Chelakkot VS; Licursi M; Rutihinda SG; Som J; Derwish L; King JJ; Pongnopparat T; Mearow K; Larijani M; Dorward AM; Hirasawa K
    Theranostics; 2018; 8(8):2134-2146. PubMed ID: 29721068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protoporphyrin IX tracer fluorescence modulation for improved brain tumor cell lines visualization.
    Piffaretti D; Burgio F; Thelen M; Kaelin-Lang A; Paganetti P; Reinert M; D'Angelo ML
    J Photochem Photobiol B; 2019 Dec; 201():111640. PubMed ID: 31734545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Her2 oncogene transformation enhances 5-aminolevulinic acid-mediated protoporphyrin IX production and photodynamic therapy response.
    Yang X; Palasuberniam P; Myers KA; Wang C; Chen B
    Oncotarget; 2016 Sep; 7(36):57798-57810. PubMed ID: 27527860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.